Partner Article

New facility spells further growth for Aesica

A NORTH EAST pharmaceutical company is investing £3 million in a new facility and aims to treble its business size by 2013.

Aesica, based at the Quorum Business Park in Newcastle, has already taken on 760 staff since it was founded by ex-Boots and BASF director Dr Robert Hardy in 2004, and has now set its sights on fetching sales of £300m inside three years.

Dr Hardy has said he plans to expand the business - which is now looking for additional manufacturing sites in Europe, India and the USA - and will use the new site in Kent to increase the production and packaging of drugs.

Adam Sims, commercial director at Aesica said: “As the market for the contract manufacture of potent drugs continues to grow, Aesica believes that the investment in the new containment facility will enable the company to significantly extend its formulation offering in this particular market.

“It was a natural progression for us to broaden our reach into this marketplace. The addition of the new facility will be of huge benefit to our current clients and all pharmaceutical companies who require potent drug product production.”

Aesica supplies manufacturing services to a host of the world’s leading pharmaceutical companies and emerging biotechnology organisations.

The firm now has manufacturing sites in the UK as well as offices in New York, San Diego and Shanghai and recently announced the acquisition of the research and development company R5.

This was posted in Bdaily's Members' News section by Ruth Mitchell .